Identifícate
Grupos
Investigadores/as
Financiamento
Resultados
Financiamento
Financiador
:
GLENMARK PHARMACEUTICALS LIMITED
Ámbito
Internacional (non UE) (1)
Carácter
Privado (1)
1 financiamentos
- 607€
datos dispoñibles desde 2021
2021
Experience In The Field of On Potential Indications of Molecules That Inhibit Nlrp3 And Potential Techniques To Use In The Design of Drugs That Inhibit Nlrp3.
euro
607,50
Contactar
Aviso legal
translate
gl
arrow_drop_down
translate
gl
arrow_drop_down
es
ca
eu
en
fr
de